Related Experiment Video
Updated: May 17, 2026
08:56
Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Accelerated cellular senescence in solid tumor therapy
1Department of Surgery, VA Puget Sound Health Care System, Seattle, WA 98108, USA. pcwu@uw.edu
Experimental Oncology
|October 17, 2012
Summary
Accelerated cellular senescence (ACS) involves cell cycle arrest in cancer cells. Some cells escape this arrest, driving cancer progression, highlighting the need for senescence-based therapies.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Accelerated cellular senescence (ACS) is a state of sustained, telomere-independent cell cycle arrest.
- Neoplastic cells undergo ACS in response to chemotherapy, radiation, oxidative stress, or oncogenic stimuli.
- A subset of tumor cells can escape ACS, leading to cancer progression.
Purpose of the Study:
- To review the current understanding of accelerated cellular senescence.
- To explore signaling pathways involved in senescence escape.
- To discuss the role of senescence biomarkers and the rationale for senescence-based therapies.
Main Methods:
- This is a review article.
- It synthesizes current evidence on accelerated cellular senescence.
- It focuses on signaling pathways, biomarkers, and therapeutic strategies.
Main Results:
- Evidence suggests that reversible ACS can be escaped by tumor cells.
- Senescence escape contributes to cancer progression.
- Understanding these mechanisms is crucial for developing new treatments.
Conclusions:
- Accelerated cellular senescence is a complex process with implications for cancer therapy.
- Targeting senescence escape pathways and utilizing senescence biomarkers are promising therapeutic avenues.
- Further research into senescence-based therapies is warranted.
More Related Videos
Related Concept Videos
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...